Australia markets close in 1 hour 12 minutes

ResMed Inc. (RMD.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
33.57+0.02 (+0.06%)
As of 02:39PM AEST. Market open.
Full screen
Previous close33.55
Bid33.57 x 51100
Ask33.58 x 25600
Day's range33.48 - 34.38
52-week range27.37 - 40.79
Avg. volume1,260,550
Market cap49.779B
Beta (5Y monthly)0.47
PE ratio (TTM)45.36
EPS (TTM)0.74
Earnings dateN/A
Forward dividend & yield0.24 (0.71%)
Ex-dividend date11 May 2022
1y target est33.79
  • Zacks

    ResMed (RMD) Q4 Earnings Beat Estimates, Gross Margin Up

    ResMed (RMD) posts better-than-expected Q4 results with continued strength in sleep and respiratory care devices sales performance.

  • Motley Fool

    ResMed (RMD) Q4 2022 Earnings Call Transcript

    Joining me on the call today are our chief executive officer, Mick Farrell, and chief financial officer, Brett Sandercock. Following our prepared remarks, we will host a Q&A session, and Mick and Brett will be joined by Rob Douglas, president and chief operating officer, and David Pendarvis, chief administrative officer and global general counsel.

  • Zacks

    ResMed (RMD) Q4 Earnings Beat Estimates

    ResMed (RMD) delivered earnings and revenue surprises of 0.68% and 0.29%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?